{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:08:11Z","timestamp":1791209291782,"version":"4.1.0"},"reference-count":41,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100012688","name":"Universit?t Rostock","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Direct in vivo imaging of myelin would greatly benefit research on demyelinating diseases such as multiple sclerosis but remains technically challenging. This study evaluated whether the amyloid-\u03b2 radiotracer [18F]Flutemetamol is suitable for PET\/CT imaging of myelin in the murine cuprizone model of demyelination. Male C57BL\/6 mice were fed 0.3% cuprizone for five weeks (n = 5) or control chow (n = 5) and subsequently underwent a 90 min dynamic [18F]Flutemetamol PET\/CT scan with a retest scan two days later. PET data were analyzed using region-of-interest-based quantification with an image-derived input function; volume of distribution (VT) was estimated by Logan graphical analysis, and percentage injected dose per milliliter (% ID\/mL) was calculated as a simplified uptake measure. Demyelination was independently validated by MRI and histology. Cuprizone treatment induced significant body weight loss and robust region-specific demyelination of the corpus callosum, confirmed by reduced myelin marker expression, increased astroglial and microglial activation, and corresponding MRI changes. In contrast, in vivo [18F]Flutemetamol PET showed rapid radiotracer washout, low brain retention, and high variability. Estimated VT values were very low and did not differ between control and cuprizone-treated mice. Similarly, % ID\/mL failed to detect group differences in any analyzed brain region and showed high test\u2212retest variability. Despite histologically confirmed demyelination and corresponding T2-weighted MRI signal alterations, [18F]Flutemetamol PET\/CT did not provide sufficient sensitivity or quantitative robustness to detect myelin loss in vivo. This negative finding might reflect a combination of tracer-related and methodological limitations, including limited spatial resolution and uncertainties in quantitative modeling, and therefore does not allow a definitive conclusion regarding the intrinsic suitability of [18F]Flutemetamol for preclinical myelin imaging.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.6c00470","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:25:54Z","timestamp":1788452754000},"page":"4893-4903","source":"Crossref","is-referenced-by-count":0,"title":["Low Uptake of [18F]Flutemetamol in the Mouse Brain Prevents Non-invasive Quantification of Myelin"],"prefix":"10.1021","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7587-8318","authenticated-orcid":true,"given":"Anna","family":"Schildt","sequence":"first","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]},{"name":"Otto von Guericke University Magdeburg , , ,","place":["Magdeburg, Germany, 39106"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Beecken","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Lindner","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]},{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Joksch","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kurth","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andre\u0301","family":"Weber","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Vollmar","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd J.","family":"Krause","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-8904","authenticated-orcid":true,"given":"Sarah","family":"Joost","sequence":"additional","affiliation":[{"name":"Rostock University Medical Center , , ,","place":["Rostock, Germany, 18057"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"9648","key":"2026100509321387700_cit1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"2026100509321387700_cit2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"2026100509321387700_cit3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"2026100509321387700_cit4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/WCO.0000000000001063","article-title":"New drugs for multiple sclerosis: new treatment algorithms","volume":"35","author":"Cree","year":"2022","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"2026100509321387700_cit5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/WCO.0000000000000692","article-title":"Remyelination in multiple sclerosis: from concept to clinical trials","volume":"32","author":"Kremer","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"2026100509321387700_cit6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol."},{"key":"2026100509321387700_cit7","doi-asserted-by":"publisher","first-page":"108990","DOI":"10.1016\/j.jneumeth.2020.108990","article-title":"Towards in vivo g-ratio mapping using MRI: Unifying myelin and diffusion imaging","volume":"348","author":"Mohammadi","year":"2021","journal-title":"J. Neurosci. Methods"},{"key":"2026100509321387700_cit8","doi-asserted-by":"publisher","first-page":"117561","DOI":"10.1016\/j.neuroimage.2020.117561","article-title":"Myelin quantification with MRI: A systematic review of accuracy and reproducibility","volume":"226","author":"van der Weijden","year":"2021","journal-title":"NeuroImage"},{"issue":"3","key":"2026100509321387700_cit9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1148\/radiol.11101362","article-title":"MR imaging of multiple sclerosis","volume":"259","author":"Filippi","year":"2011","journal-title":"Radiology"},{"key":"2026100509321387700_cit10","doi-asserted-by":"publisher","first-page":"117744","DOI":"10.1016\/j.neuroimage.2021.117744","article-title":"Can MRI measure myelin? Systematic review, qualitative assessment, and meta-analysis of studies validating microstructural imaging with myelin histology","volume":"230","author":"Lazari","year":"2021","journal-title":"NeuroImage"},{"issue":"24","key":"2026100509321387700_cit11","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1073\/pnas.0600769103","article-title":"Imaging of CNS myelin by positron-emission tomography","volume":"103","author":"Stankoff","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"24","key":"2026100509321387700_cit12","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.1016\/J.BMC.2010.10.018","article-title":"A novel PET marker for in vivo quantification of myelination","volume":"18","author":"Wu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"2026100509321387700_cit13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/ana.23965","article-title":"Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord","volume":"74","author":"Wu","year":"2013","journal-title":"Ann. Neurol."},{"issue":"11","key":"2026100509321387700_cit14","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/1352458514526941","article-title":"PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis","volume":"20","author":"de Paula Faria","year":"2014","journal-title":"Mult. Scler. J."},{"key":"2026100509321387700_cit15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.neuroimage.2013.10.057","article-title":"PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [11C]CIC and [11C]MeDAS","volume":"87","author":"de Paula Faria","year":"2014","journal-title":"NeuroImage"},{"issue":"2","key":"2026100509321387700_cit16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00259-019-04516-z","article-title":"Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB","volume":"47","author":"Auvity","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"2026100509321387700_cit17","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00259-012-2178-9","article-title":"Pharmacokinetics of [ 18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer\u2019s disease","volume":"39","author":"Snellman","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"2026100509321387700_cit18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2967\/jnumed.121.263281","article-title":"Comparison of 11C-Pittsburgh Compound B and 18F-Flutemetamol White Matter Binding in PET","volume":"63","author":"Zeydan","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"Suppl. 1","key":"2026100509321387700_cit19","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1016\/j.nima.2010.11.092","article-title":"Fundamental Limits of Spatial Resolution in PET","volume":"648","author":"Moses","year":"2011","journal-title":"Nucl. Instrum. Methods Phys. Res., Sect. A"},{"issue":"11","key":"2026100509321387700_cit20","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain","volume":"50","author":"Choi","year":"2009","journal-title":"J. Nucl. Med."},{"key":"2026100509321387700_cit21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"24","key":"2026100509321387700_cit22","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.3390\/ijms232416093","article-title":"Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model","volume":"23","author":"Leo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026100509321387700_cit23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12031-015-0595-5","article-title":"Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice","volume":"57","author":"Goldberg","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"13","key":"2026100509321387700_cit24","doi-asserted-by":"publisher","first-page":"10564","DOI":"10.3390\/ijms241310564","article-title":"The Cuprizone Mouse Model: A Comparative Study of Cuprizone Formulations from Different Manufacturers","volume":"24","author":"Beecken","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"2026100509321387700_cit25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.neuroscience.2005.07.014","article-title":"A three-dimensional digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy","volume":"135","author":"Ma","year":"2005","journal-title":"Neuroscience"},{"issue":"7","key":"2026100509321387700_cit26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"1","key":"2026100509321387700_cit27","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1038\/s41467-026-72383-y","article-title":"A comparative transcriptomic analysis of mouse demyelination models and multiple sclerosis lesions","volume":"17","author":"Aboelnour","year":"2026","journal-title":"Nat. Commun."},{"issue":"3","key":"2026100509321387700_cit28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/ijms25031445","article-title":"How to Use the Cuprizone Model to Study De- and Remyelination","volume":"25","author":"Kipp","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026100509321387700_cit29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model for demyelination","volume":"117","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol. Scand., Suppl."},{"issue":"5","key":"2026100509321387700_cit30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/S00259-013-2682-6","article-title":"PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [ 11 C]MeDAS, [ 11 C]CIC and [ 11 C]PIB","volume":"41","author":"de Paula Faria","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"2026100509321387700_cit31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168667","article-title":"Standardized Input Function for 18F-FDG PET Studies in Mice: A Cautionary Study","volume":"12","author":"Meyer","year":"2017","journal-title":"PLoS One"},{"key":"2026100509321387700_cit32","doi-asserted-by":"publisher","first-page":"1372379","DOI":"10.3389\/fnume.2024.1372379","article-title":"Deep-learning-derived input function in dynamic 18FFDG PET imaging of mice","volume":"4","author":"Kuttner","year":"2024","journal-title":"Front. Nucl. Med."},{"issue":"5","key":"2026100509321387700_cit33","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J. Nucl. Med."},{"issue":"4","key":"2026100509321387700_cit34","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.neuroimage.2012.02.032","article-title":"Characterisation of partial volume effect and region-based correction in small animal positron emission tomography (PET) of the rat brain","volume":"60","author":"Lehnert","year":"2012","journal-title":"NeuroImage"},{"key":"2026100509321387700_cit35","doi-asserted-by":"publisher","first-page":"100982","DOI":"10.1016\/j.eclinm.2021.100982","article-title":"18F-florbetapir PET\/MRI for quantitatively monitoring myelin loss and recovery in patients with multiple sclerosis: A longitudinal study","volume":"37","author":"Zhang","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"2","key":"2026100509321387700_cit36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00259-019-04533-y","article-title":"18FFlorbetapir PET\/MR imaging to assess demyelination in multiple sclerosis","volume":"47","author":"Carotenuto","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"12","key":"2026100509321387700_cit37","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.bpsc.2025.03.013","article-title":"Accelerated Aging of White Matter in Late-Life Depression: Evidence From 18F-Flutemetamol Positron Emission Tomography Imaging","volume":"10","author":"Takamiya","year":"2025","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"issue":"7","key":"2026100509321387700_cit38","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00259-014-2753-3","article-title":"Amyloid PET imaging in Alzheimer\u2019s disease: a comparison of three radiotracers","volume":"41","author":"Landau","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"2026100509321387700_cit39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3233\/JAD-170582","article-title":"18F - Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and 18F-Fludeoxyglucose","volume":"62","author":"Kalheim","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"2026100509321387700_cit40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2967\/jnumed.123.266896","article-title":"Myelin Imaging of the Spinal Cord in Animal Models and Patients with Multiple Sclerosis Using [11C]MeDAS PET: A Translational Study","volume":"66","author":"van der Weijden","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"818","key":"2026100509321387700_cit41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adt5585","article-title":"SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis","volume":"17","author":"Ullrich Gavilanes","year":"2025","journal-title":"Sci. Transl. Med."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.6c00470","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4893\/68201761\/mp6c00470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4893\/68201761\/mp6c00470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:16Z","timestamp":1791208156000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/4893\/5405433\/Low-Uptake-of-18F-Flutemetamol-in-the-Mouse-Brain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6c00470","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}